89 related articles for article (PubMed ID: 26276521)
1. Estimating informal care inputs associated with EQ-5D for use in economic evaluation.
Rowen D; Dixon S; Hernández-Alava M; Mukuria C
Eur J Health Econ; 2016 Jul; 17(6):733-44. PubMed ID: 26276521
[TBL] [Abstract][Full Text] [Related]
2. Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) Tool.
Gheorghe M; Hoefman RJ; Versteegh MM; van Exel J
Pharmacoeconomics; 2019 Jan; 37(1):93-103. PubMed ID: 30151734
[TBL] [Abstract][Full Text] [Related]
3. Predicting Productivity Losses from Health-Related Quality of Life Using Patient Data.
Mukuria C; Rowen D; Hernández-Alava M; Dixon S; Ara R
Appl Health Econ Health Policy; 2017 Oct; 15(5):597-614. PubMed ID: 28364369
[TBL] [Abstract][Full Text] [Related]
4. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
[TBL] [Abstract][Full Text] [Related]
5. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.
Hernández Alava M; Wailoo AJ; Ara R
Value Health; 2012 May; 15(3):550-61. PubMed ID: 22583466
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics and determinants of informal care in chronic diseases in Hungary: a comparative analysis].
Beretzky Z; Péntek M
Orv Hetil; 2017 Dec; 158(52):2068-2078. PubMed ID: 29285940
[TBL] [Abstract][Full Text] [Related]
7. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.
Péntek M; Gulácsi L; Brodszky V; Baji P; Boncz I; Pogány G; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Iskrov G; Schieppati A; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():89-98. PubMed ID: 27062257
[TBL] [Abstract][Full Text] [Related]
8. Zero-inflated endogenous count in censored model: effects of informal family care on formal health care.
Lee MJ; Kim YS
Health Econ; 2012 Sep; 21(9):1119-33. PubMed ID: 22641305
[TBL] [Abstract][Full Text] [Related]
9. Mapping the COPD Assessment Test onto EQ-5D.
Hoyle CK; Tabberer M; Brooks J
Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
[TBL] [Abstract][Full Text] [Related]
10. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
11. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
[TBL] [Abstract][Full Text] [Related]
12. EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care.
Mathews WC; May S
Health Qual Life Outcomes; 2007 Jan; 5():5. PubMed ID: 17254361
[TBL] [Abstract][Full Text] [Related]
13. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.
Greene ME; Rader KA; Garellick G; Malchau H; Freiberg AA; Rolfson O
Clin Orthop Relat Res; 2015 Nov; 473(11):3383-90. PubMed ID: 25488404
[TBL] [Abstract][Full Text] [Related]
14. Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.
Ramos-Goñi JM; Rand-Hendriksen K; Pinto-Prades JL
Value Health; 2016 Jun; 19(4):478-86. PubMed ID: 27325340
[TBL] [Abstract][Full Text] [Related]
15. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
Cleemput I
Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
[TBL] [Abstract][Full Text] [Related]
16. Does the EQ-5D measure quality of life in schizophrenia?
Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
[TBL] [Abstract][Full Text] [Related]
17. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.
Maes IH; Joore MA; Cima RF; Vlaeyen JW; Anteunis LJ
Ear Hear; 2011; 32(4):428-35. PubMed ID: 21221004
[TBL] [Abstract][Full Text] [Related]
18. A median model for predicting United States population-based EQ-5D health state preferences.
Shaw JW; Pickard AS; Yu S; Chen S; Iannacchione VG; Johnson JA; Coons SJ
Value Health; 2010; 13(2):278-88. PubMed ID: 19961566
[TBL] [Abstract][Full Text] [Related]
19. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
